Clearside Biomedical (CLSD) IPO Opens Up 14%

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/27/2026

1. AVGO
2. CDNS
3. SPY
4. META
5. ANT
6. SSD
7. AAPL
8. JBLU
9. PECO
10. ARTV

Go back to Clearside Biomedical (CLSD) IPO Opens Up 14%

Clearside Biomedical (CLSD) Prices 7.2M Common Stock IPO at $7/Share

June 2, 2016 6:57 AM EDT

Clearside Biomedical, Inc. (Nasdaq: CLSD), a late-stage clinical biopharmaceutical company developing first-in-class drug therapies to treat blinding diseases of the eye, announced the pricing of its initial public offering of 7,200,000 shares of its common stock at a public offering price of $7.00 per share. In addition, Clearside has granted the underwriters a 30-day option to purchase up to an additional 1,080,000 shares of common stock at the public offering price, less underwriting discounts and commissions. The shares are scheduled to begin trading on the NASDAQ Global Market on June 2, 2016 under the ticker... More